APL, a model disease for cancer therapies? (Q34435486)

2 August 2017

1 reference

title

APL, a model disease for cancer therapies? (English)

1 reference

2 August 2017

H de Thé

1

1 reference

2 August 2017

M K Chelbi-Alix

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

2 August 2017

1 reference

2 August 2017

20

1 reference

2 August 2017

49

1 reference

2 August 2017

7136-7139

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204851

2 August 2017

0 references

cites work

RAR-independent RXR signaling induces t(15;17) leukemia cell maturation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

Nuclear bodies (NBs): a newly "rediscovered" organelle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

Two critical hits for promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

Role of the histone deacetylase complex in acute promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

SUMO, ubiquitin's mysterious cousin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

P53 and PML: new partners in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

7 January 2021

Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

7 January 2021

Retinoic acid and arsenic: towards oncogene-targeted treatments of acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

7 January 2021

Role and fate of PML nuclear bodies in response to interferon and viral infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204851

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204851

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference